Vital Laboratories Private Limited
Avnish Rajput is an experienced professional in the field of quality control and laboratory management. Currently serving as Quality Control Manager at VITAL LABORATORIES PRIVATE LIMITED since October 2021, Avnish previously held the position of Team Leader in the QC department at Ipca Laboratories Limited from July 2018 to the present. Prior experience includes working as Officer in the ATS department at Teva API India Limited from July 2013 to July 2018. Avnish Rajput possesses a post graduate degree in Organic Chemistry and completed 12th grade in the Science Group from UP Board Allahabad between 1994 and 1996.
This person is not in any offices
Vital Laboratories Private Limited
We, Vital Laboratories Private Limited, are manufactures of pharmaceutical API’s. We started our journey in 1998 with manufacturing Quinine Derivatives and today we are one of the largest manufacturers of Quinine Derivatives globally. We have enlarged our product basket to more than 45 API’S in our product portfolio covering various therapeutic segments. We manufacture various herbal based APIs and synthetic APIs; and market to both Domestic and International Markets. We have a strong portfolio of products having Herbal origin which involves the process of Extraction of the product from medicinal plants. Besides API of herbal origin, we have built up a strong portfolio of Synthetic APIs. Our product portfolio of APIs covering various therapeutic segments like anti-malarial, anti-spasmodic, vitamins, auto-immune, anti-viral, anti- bacterial, muscle relaxants, NSAIDs, etc. Vital is a partner to almost all major pharmaceutical companies in India and has a global reach through its strategic partnerships. Our Company’s strength and its growth is a result of our philosophy to manufacture API right from scratch. Hence ensuring backward integration for most of our products is a key to our success. In the pursuit of our endeavour towards backward integration, through the cultivation in our farms in Australia, we have secured our business of Hyoscine derivatives. Similar integrations in Quinine derivatives and other businesses have strengthened Vital’s position as a reliable partner.